The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 12, 2019

Filed:

Feb. 01, 2017
Applicant:

Roche Palo Alto Llc, South San Francisco, CA (US);

Inventors:

Michael Patrick Dillon, San Francisco, CA (US);

Ronald Charles Hawley, Mountain View, CA (US);

Li Chen, Shanghai, CN;

Lichun Feng, Shanghai, CN;

Minmin Yang, Shanghai, CN;

Assignee:

Roche Palo Alto LLC, South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/41 (2006.01); A61K 31/4439 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01); C07D 257/04 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 403/14 (2006.01); C07D 405/12 (2006.01); C07D 407/10 (2006.01); C07D 413/10 (2006.01); C07D 417/10 (2006.01); C07D 491/10 (2006.01); C07D 241/12 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 409/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 491/107 (2006.01); C07D 498/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/41 (2013.01); A61K 31/4439 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); C07D 241/12 (2013.01); C07D 257/04 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 407/10 (2013.01); C07D 409/12 (2013.01); C07D 413/10 (2013.01); C07D 417/10 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 491/10 (2013.01); C07D 491/107 (2013.01); C07D 498/08 (2013.01);
Abstract

A method of antagonizing P2Xand/or P2Xreceptors or treating a disease misregulation of P2Xand/or P2Xreceptors treating a patient with a compound of formula I wherein R, R, R, R, Rand Rare as defined herein, or a pharmaceutically acceptable salt thereof. wherein, Ris optionally substituted tetrazolyl, Ris optionally substituted phenyl, optionally substituted pyridinyl or optionally substituted thienyl, and R, R, Rand Rare as defined herein. Also provided are methods of using the compounds for treating diseases associated with the P2Xand/or a P2Xreceptor antagonist and methods of making the compounds.


Find Patent Forward Citations

Loading…